Trials / Completed
CompletedNCT02871544
Predictive Value of Dynamic Combination of BNP and NGAL for the Prognosis of Patients With Sepsis
Predictive Value of Dynamic Combination of B-type Natriuretic Peptide and Neutrophil Gelatinase-associated Lipocalin for the Prognosis of Patients With Sepsis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 124 (actual)
- Sponsor
- Southeast University, China · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Objective: to clarify the predictive value of brain natriuretic peptide (BNP) in combination with neutrophil gelatinase associated lipocalin (NGAL) for the prognosis of patients with sepsis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | BNP and NGAL |
Timeline
- Start date
- 2015-06-01
- Primary completion
- 2016-02-01
- Completion
- 2016-02-01
- First posted
- 2016-08-18
- Last updated
- 2016-08-18
Source: ClinicalTrials.gov record NCT02871544. Inclusion in this directory is not an endorsement.